Bavarian Nordic Capital Markets Day 2017

September 21, 2017

Bavarian Nordic will host a capital markets day for investors and analysts on Thursday, September 21, 2017 in New York City.

Join this half-day event where the management of Bavarian Nordic, collaborators from the National Cancer Institute and key opinion leaders within the field of oncology and infectious diseases will give presentations on the company's business and future plans and opportunities.

Presentations will be webcasted live and on-demand.

General Agenda

08:15 - 08:45 Registration and breakfast
08:45 - 10:30 Presentations
10:30 - 10:45 Break
10:45 - 12:30 Presentations
12:30 - 13:30 Lunch and informal networking with management


Seth Lewis
Vice President Investor Relations (US)
Tel: +1 978 341 5271

Rolf Sass Sørensen
Vice President Investor Relations (EU)
Tel: +45 61 77 47 43

Register / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

Bavarian Nordic A/S [BVNRY] US$942 MM MCap
Vaccines for in­fec­tious dis­eas­es and on­col­o­gy. Can­cer vaccines in com­bo with mul­ti­ple check­point in­hibi­tors (Roche/Mer­ck/BMS). Uni­ver­sal RSV vaccine with pos­i­tive phase 2 da­ta. Re­cent con­tract from US... [more in­for­ma­tion]

Event Contact

Clayton Robertson
Solebury Trout